Literature DB >> 3912463

F41 antigen as a virulence factor in the infant mouse model of Escherichia coli diarrhoea.

A Bertin.   

Abstract

The properties responsible for the virulence in infant mice of the bovine enterotoxigenic Escherichia coli strain B41 were investigated. A B41K99- variant previously found to be nearly as virulent as the original strain B41 (B41K99+) possessed F41 antigen and haemagglutinating properties. Two variants that did not haemagglutinate sheep and human erythrocytes were isolated from strain B41K99-. These variants simultaneously lost their ability to agglutinate with F41 antiserum and their haemagglutinating properties. They still produced heat-stable enterotoxin. The first B41K99-F41- variant was much less virulent than strains B41K99+ and B41K99-, the second was not virulent at all. F41 properties were not acquired by other E. coli strains by plasmid transfers. Non-haemagglutinating variants could not be obtained from the original strain B41K99+. However, a B41K99+F41- strain was obtained by a four-step procedure: (i) spontaneous loss of the K99 plasmid, (ii) obtaining a nalidixic acid-resistant mutant, (iii) obtaining a non-haemagglutinating F41- variant, (iv) reacquisition of the K99 plasmid. This B41NalrK99+F41- strain, although producing heat-stable toxin, was not at all virulent, whereas reacquisition of the K99 plasmid by the strain B41NalrF41+ restored virulence. These results show that F41 antigen is an important virulence factor of strain B41 in the infant mouse model.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3912463     DOI: 10.1099/00221287-131-11-3037

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  9 in total

1.  Replicon typing of virulence plasmids of enterotoxigenic Escherichia coli isolates from cattle.

Authors:  J G Mainil; F Bex; P Dreze; A Kaeckenbeeck; M Couturier
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

2.  Comparison of susceptibility of inbred and outbred infant mice to Escherichia coli heat-stable enterotoxin STa.

Authors:  A Bertin
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Susceptibility of infant mice to F5 (K99) E. coli infection: differences in glycosyltransferase activities in intestinal mucosa of inbred CBA and DBA/2 strains.

Authors:  P A Grange; M Mouricout
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

4.  Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.

Authors:  Wilson B Luiz; Juliana F Rodrigues; Joseph H Crabb; Stephen J Savarino; Luis C S Ferreira
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

5.  Involvement of the MN blood group antigen in shear-enhanced hemagglutination induced by the Escherichia coli F41 adhesin.

Authors:  D E Brooks; J Cavanagh; D Jayroe; J Janzen; R Snoek; T J Trust
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

6.  Passive protection of suckling infant mice against F41-positive enterotoxigenic Escherichia coli strains by intravenous inoculation of the dams with monoclonal antibodies against F41.

Authors:  M Duchet-Suchaux; P Menanteau; F G van Zijderveld
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

7.  Pilus-mediated binding of bovine enterotoxigenic Escherichia coli to calf small intestinal mucins.

Authors:  M A Mouricout; R A Julien
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

8.  Protective antigens against enterotoxigenic Escherichia coli O101:K99,F41 in the infant mouse diarrhea model.

Authors:  M Duchet-Suchaux
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

9.  Re-evaluation of a Neonatal Mouse Model of Infection With Enterotoxigenic Escherichia coli.

Authors:  Carla J Carroll; Dianna M Hocking; Kristy I Azzopardi; Judyta Praszkier; Vicki Bennett-Wood; Kaylani Almeida; Danielle J Ingle; Sarah L Baines; Marija Tauschek; Roy M Robins-Browne
Journal:  Front Microbiol       Date:  2021-03-18       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.